Periodoncia.Eley.6a.Ed

More documents

Recommendations

Info

Mecanismos de producción de la enfermedad 97 © ELSEVIER. Fotocopiar sin autorización es un delito. destruida con formalina. Se prepararon células B específicas de antígeno a partir de esplenocitos mediante la unión de células CD43+ a placas de Petri recubiertas con anticuerpo anti-CD43 para eliminar las células T, y las células no unidas se pasaron a través de una columna de lana de nailon para deplecionar las células accesorias. Las células retenidas se recogieron y se unieron a placas de Petri recubiertas con A. actinomycetemcomitans para enriquecer las células B unidas a A. actinomycetemcomitans (AAB, A. actinomycetemcomitans-binding B cells). También se recogieron las células B no unidas a A. actinomycetemcomitans (ANB, A. actinomycetemcomitansnon binding B cells) y las células B de los ratones donantes no inmunizados (NIB, non-immunized B cells). Cada tipo de célula B se inyectó en un grupo de ratones receptores, que fueron infectadas por vía oral con A. actinomycetemcomitans viable. Al final, los valores de anticuerpos contra A. actinomycetemcomitans en suero y líquido crevicular fueron significativamente mayores en los ratones receptores a los que se les transfirió AAB en comparación con los ratones receptores a los que se les transfirió ANB o NIB. Se observó un número notablemente elevado de células formadoras de anticuerpos en el bazo de los ratones receptores con AAB, y estos ratones también mostraron una resorción ósea significativamente elevada en comparación con los otros grupos. Estos resultados sugieren que las células B pueden contribuir a la resorción ósea periodontal y que para que ésto se produzca se necesita la estimulación antigénica de las células B. Kawai et al. (2007) examinaron si la inducción de una respuesta inmunitaria adaptativa contra la colonización oral de Pasteurella pneumotropica no patogénica, mediante la inmunización con la bacteria estrechamente relacionada desde el punto de vista filogenético A. actinomycetemcomitans, podría provocar una pérdida de hueso periodontal en ratones. La inducción de esta respuesta adaptativa provocaba una pérdida de hueso periodontal dependiente del RANKL en los ratones. Bibliografía Abiko Y, Hayakawa M, Murai S, et al: Glycylprolyl dipeptidyl aminopeptidase from Bacteroides gingivalis, J Dent Res 64:106–111, 1985. Adriaens PA, Claeys GW, De Boever JA: Colonization of human dentin by a mixed flora of oral bacteria in vitro, Caries Res 18, , 1984, 160Abstr. 21. Adriaens PA, Loesche WJ, De Boever JA: Bacteriology of the flora present in the roots of periodontally diseased teeth, J Dent Res 66, , 1987, 338Abstract 1855. Adriaens PA, De Boever JA, Loesche WJ: Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans, J Periodontol 59:222–230, 1988a. Adriaens PA, Edwards CA, De Boever JA, et al: Ultrastructural observations on bacterial invasion in cementum and radicular dentin of periodontally diseased human teeth, J Periodontol 59:493–503, 1988b. Aduse-Opoku J, Muir J, Slaney JM, et al: Characterization, genetic analysis and expression studies of a protease antigen (PrpR1) of Porphyromonas gingivalis W50, Infect Immun 63:4744–4754, 1995. Aduse-Opoku J, Slaney JM, Rangarajan M, et al: Characterization of an adherence and antigen determinant of the Arg 1 protease Porphyromonas gingivalis which is present on multiple gene products, Infect Immun 64:2532–2539, 1996. Allenspach-Petrzilka GE, Guggenheim B: Bacterial invasion of the periodontium; an important factor in the pathogenesis of periodontitis? J Clin Periodontol 10:609–617, 1983. Al-Rasheed A, Scheerens H, Rennick DM, et al: Accelerated alveolar bone loss in mice lacking interleukin-10, J Dent Res 82:632–635, 2003. Al-Rasheed A, Scheerens H, Srivastava AK, et al: Accelerated alveolar bone loss in mice lacking interleukin-10: late onset, J Periodontal Res 39:194–198, 2004. Alayan J, Ivanovski S, Gemmell E, et al: Deficiency of inos contributes to Porphyromonas gingivalis-induced tissue damage, Oral Microbiol Immunol 21:360– 365, 2006. Amano A: Molecular interaction of Porphyromonas gingivalis with host cells: implications for the microbial pathogenesis of periodontal disease, J Periodontol 74:90–96, 2003. Andrian E, Grenier D, Rouabhia M: Porphyromonas gingivalis-epithelial cell interactions in periodontitis, J Dent Res 85:392–403, 2006. Aoyagi T, Sugawara- Aoyagi M, Yamazaki K, et al: Interleukin-4 (IL-4) and IL-6- producing memory T- cells in peripheral blood and gingival tissues in periodontitis patients with high serum antibody titres to Porphyromonas gingivalis, Oral Microbiol Immunol 10:304–310, 1995. Arakawa S, Kuramitsu H: Cloning and sequence analysis of the chymotrypsin-like protease from Treponema denticola, Infect Immun 62:3424–3433, 1994. Aronsen KF, Ekelund G, Kindmark CO, et al: Sequential changes in plasma proteins after myocardial infarction, Scand J Clin Lab Invest 29:127–134, 1972. Baggiolini M, Schnyder J, Bretz U, et al. Cellular mechanisms of proteinase release from inflammatory cells and degradation of extracellular proteins. In: Evered D, Whelan J, Ed. Protein degradation in health and disease Ciba Foundation Symposium: 75, 105- 121.2005, Baker PJ: Genetic control of the immune response in pathogenesis, J Periodontol 76:2042–2046, 2005. Balkwill FR, Burke F: The cytokine network, Immunol Today 9:299–304, 1989. Banda MJ, Rice AJ, Griffin GL, et al: a-1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase, J Biol Chem 363:4481–4484, 1988a. Banda MJ, Rice AJ, Griffin GL, et al: The inhibitory complex of human a-1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant, J Exp Med 167:1608–1615, 1988b. Barkocy-Gallagher GA, Han N, Patti JM, et al: Analysis of the prtP gene encoding porphypain, a cysteine proteinase of Porphyromonas gingivalis, J Bacteriol 176:2734– 2741, 1996. Barkocy-Gallagher GA, Foley WF, Lantz MS: Activities of the Porphyromonas gingivalis prtP proteinase determined by construction of prtP deficient mutants and expression of the gene in Bacteroides species, J Bacteriol 181:246–255, 1999. Barrett AJ: Introduction: the classification of proteinases, Ciba Found Symp 75:1–13, 1980. Barrett AJ, Starky PM: The interaction of alpha2-macroglobulin with proteases, characteristics and specificity of reaction, and a hypothesis concerning its molecular mechanism, Biochem J 133:709–724, 1973. Bartold PM: Proteoglycans in the periodontium. Structure, role and function, J Periodontal Res 22:431–444, 1987. Bartold PM, Wiebkin OW, Thonard JC: The effect of oxygen-derived free radicals on gingival proteoglycans and hyaluronic acid, J Periodontal Res 19:390–400, 1984. Barua PK, Neiders ME, Topolnyeky A, et al: Purification of an 80:000 Mr glycylprolyl peptidase from Bacteroides gingivalis, Infect Immun 57:2522–2528, 1989. Battino M, Bullon P, Wilson M, et al: Oxidative injury and inflammatory periodontal diseases: the challenge of anti-oxidants to free radicals and reactive oxygen species, Crit Rev Oral Biol Med 10:458–476, 1999. Bedi GS, Williams T: Purification and characterization of a collagen-degrading protease from Porphyromonas gingivalis, J Biol Chem 269:599–606, 1994. Beikler T, Ehmke B, Wittstock M, et al: Serum antibody reactivity against recombinant PrtC of Porphyromonas gingivalis following periodontal therapy, J Periodontal Res 38:276–281, 2003. Beikler T, Peters U, Prior K, et al: Sequence variations in rgpA and rgpB of Porphyromonas gingivalis in periodontitis, J Periodontal Res 40:193–198, 2005. Beklen A, Ainola M, et al: mmps, IL-1, and TNF are regulated by IL-17 in periodontitis, J Dent Res 86:347–351, 2007. Berglundh T, Donati M: Aspects of adaptive host response in periodontitis, J Clin Periodontol 32:87–107, 2005. Birkedal-Hansen H, Moore W, Bodden M, et al: Matrix metalloproteinases: a review, Crit Rev Oral Biol Med 4:197–250, 1993. Birkedal-Hansen H: Role of matrix metalloproteinases in human periodontal diseases, J Periodontol 64:474–484, 1993. Birkedal-Hansen H, Taylor RE, Zambon JJ, et al: Characterization of collagenolytic activity from strains of Bacteroides gingivalis, J Periodontal Res 23:258–264, 1988. Bodineau A, Godeau G, Brousse N, et al: Langerhans cells express matrix metalloproteinases 9 and 2 and tissue inhibitors of metalloproteinases 1 and 2 in healthy human gingival tissue and in periodontitis, Oral Microbiol Immunol 21:197– 200, 2006. Booth V, Downes J, Van den Berg J, et al: Gram-positive anaerobic bacilli in human periodontal disease, J Periodontal Res 39:213–220, 2004. Booth V, Ö Solakoglu N, Bavisha, et al: Serum IgG1 and IgG2 antibody responses to Porphyromonas gingivalis in patients with periodontitis, Oral Microbiol Immunol 21:93–99, 2006. Booth V, Cox SW, Rodriguez Gonzalez EM, et al: Elastase activity in GCF and saliva relates to both clinical parameters and protease inhibitor levels in patients with severe periodontitis, Periodontal Practice Today 4:129–138, 2007. Bossard MJ, Tomaszek TA, Thompson SK, et al: Proteolytic activity of human osteoclast cathepsin K: Expression, purification, activation and substrate identification, J Biol Chem 271:12517–12524, 1996. Bostanci N, Allaker R, Johansson U, et al: Interleukin-1a stimulation in monocytes by periodontal bacteria: antagonistic effects of Porphyromonas gingivalis, Oral Microbiol Immunol 22:52–60, 2007a. Bostanci N, Ilgenli T, Emingil G, et al: Differential expression of receptor activator of nuclear factor-kappab ligand and osteoprotegerin mRNA in periodontal diseases, J Periodontal Res 42:287–293, 2007b. Bourgeau G, Laponte H, Péloquin P, et al: Cloning, expression and sequencing of a protease gene (tpr) from Porphyromonas gingivalis W83 in Escherichia coli, Infect Immun 60:3186–3192, 1992. Brock GR, Butterworth CJ, Matthews JB, et al: Local and systemic total antioxidant capacity in periodontitis and health, J Clin Periodontol 31:515–521, 2004. Bulkacz J, Newman MG, Socransky SS, et al: Phospholipase A activity of micro-organisms from dental plaque, Microbiology Letters 10:79–88, 1979. Bulkacz J, Erbland JF, MacGregor J: Phospholipase A in supernatants from cultures of Bacteroides melaninogenicus, Biochim Biophys Acta 664:148–155, 1981.
98 Periodoncia Bulkacz J, Schuster GS, Singh B, et al: Phospholipase A activity of extracellular products from Bacteroides melaninogenicus on epithelial tissue cultures, J Periodontal Res 20:146–153, 1985. Burleigh MC: Degradation of collagen by non-specific proteinases. In Barrett AJ, editor: Proteinases in Mammalian Cells and Tissues, Amsterdam, 1977, Elsevier/North- Holland Biomedical Press, pp 185–209. Califano JV, Pace Gunsolly JC, et al: Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early onset periodontitis, Oral Microbiol Immunol 12:20–26, 1997a. Califano JV, Gunsolly JC, Schenkein HA, et al: A comparison of igg antibody reactive with Bacteroides forsythus and Porphyromonas gingivalis in adult and early onset periodontitis, J Periodontol 68:734–738, 1997b. Califano JV, Chou D, Lewis JP, et al: Antibody reactive with Porphyromonas gingivalis hemagglutinin in chronic and generalized aggressive periodontitis, J Periodontal Res 39:263–268, 2004. Camerer E, Huang W, Coughlin SR: Tissue factor and factor X dependent activation of protease-activated receptor-2 by factor VII, Proc N Y Acad Sci 97:5255–5260, 2000. Cantin A, North SA, Hubbard RC: Normal alveolar epithelial lining fluid contains high levels of glutathione, J Appl Physiol 63:152–157, 1987. Cappuyns I, Gugerli P, Mombelli A: Viruses in periodontal disease – a review, Oral Dis 11:219–229, 2005. Carlsson J, Hofling JF, Sundqvist GK: Degradation of albumin, haemopexin, heptoglobin and transferrin by black-pigmented Bacteroides species, J Med Microbiol 18:39–46, 1984a. Carlsson J, Hermann BF, Hofling JF, et al: Degradation of the human proteinase inhibitors alpha-1-antitrypsin and alpha-2-macroglobulin by Bacteroides gingivalis, Infect Immun 43:644–648, 1984b. Carranza FA, Saglie FR, Newman MG, et al: Scanning and transmission electron microscopic study of tissue-invading microorganisms in localised juvenile periodontitis, J Periodontol 54:598–617, 1983. Carrell RW, Boswell DR: The serpins: the superfamily of plasma serine proteinase inhibitors, Barrett AJ, Salvensen G, editors: Proteinase Inhibitors, 12, Research Monographs in Cell and Tissue Physiology, 1986, pp 403–420. Catkins CC, Platt K, Potempta J, et al: Inactivation of tumor necrosis factor alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion, J Biol Chem 273:6611–6614, 1998. Champaiboon C, Yongvanitchit K, Pichyangkul S, et al: The immune modulation of B-cell responses by Porphyromonas gingivalis and interleukin-10, J Periodontol 71:468–475, 2000. Chapple LC: The role of free radicals and antioxidants in the pathogenesis of the inflammatory periodontal diseases, J Cell Mol Pathol 49:M247–M255, 1996. Chapple ILC: Reactive oxygen species and antioxidants in inflammatory diseases, J Clin Periodontol 24:287–296, 1997. Chapple ILC, Brock G, Eftimiadi C, et al: Glutathione in gingival crevicular fluid and its relationship to local antioxidant capacity in periodontal health and disease, J Mol Pathol 55:367–373, 2002. Chapple ILC, Mason GM, Matthews JB, et al: Enhanced chemiluminescence assay for measuring the total antioxidant capacity of serum, saliva and crevicular fluid, Ann Clin Biochem 34:412–421, 1997. Chen ECS, McLaughlin R: Taxonomy and virulence of oral spirochetes, Oral Microbiol Immunol 15:1–9, 2000. Chen Z, Potempa J, Polanowski A, et al: Purification and characterization of a 50-kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis, J Bio Chem 267:18896–18901, 1992. Choi JI, Borrello MA, Smith ES, et al: Polorization of Porphyromonas gingivalis-specific helper T-cell subsets by prior immunization with Fusobacterium nucleatum, Oral Microbiol Immunol 15:181–187, 2000. Choi BK, Moon SY, Cha JA, et al: Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii, J Periodontol 76:813–820, 2005. Christersson LA, Wikesjö UMA, Albini B, et al: Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. 1. Light, immunofluorescent and electron microscopic studies, J Periodontol 58:529–539, 1987. Ciborwski P, Nishikata M, Allen RD, et al: Purification and characterization of two forms of high molecular weight cysteine proteinase (porphypain) from Porphyromonas gingivalis, J Bacteriol 176:4549–4557, 1994. Claesson R, Edlund MB, Persson S, et al: Production of volatile sulphur compounds by various Fusobacterium species, Oral Microbiol Immunol 5:137–142, 1990. Coates ARM: The Chaperonins, London, 1996, Academic Press, 267–296. Cohen N, Morisset J, Emilie D: Induction of tolerance by Porphyromonas gingivalis on apcs: A mechanism implicated in periodontal infection, J Dent Res 83:384–387, 2004. Cole KC, Seymour GJ, Powell RN: The autologous mixed lymphocyte relations (AMLR) using periodontal lymphocytes, J Dent Res 65:473, 1986. Cole KC, Seymour GJ, Powell RN: Phenotype and functional analysis of T-cells extracted from chronically inflamed human periodontal tissues, J Periodontol 58:569–573, 1987. Compton SJ, Cairnes JA, Holgate ST, et al: Interaction of mast cell tryptase with endothelial cells to stimulate inflammatory recruitment, Int Arch Allergy Immunol 118:204–205, 1999. Compton SJ, Renaux B, Wijesuriya SJ, et al: Glycosylation and activation of protease-activated receptor-2(PAR 2 ) by human mast cell tryptase, Br J Pharmacol 134:705–718, 2001. Cope G, Thorpe G, Holder R, et al: Serum and tissue antioxidant capacity in cervical intraepithelial neoplasia investigated by an enhanced chemiluminescence reaction, Ann Clin Biochem 36:86–93, 1999. Coughlin SR: Thrombin signalling and protease-activated receptors, Nature 407:258–264, 2000. Courant P, Bader H: Bacteroides melaninogenicus and its products in the gingiva of man, Periodontics 4:131–136, 1966. Cox SW: Extending their scope of gingival crevicular fluid elastase research, Oral Dis 1:103–105, 1995. Cox SW, Eley BM: Preliminary studies on cysteine and serine proteinase activities in inflamed human gingiva using different 7-amino-4-trifluoromethyl coumarin substrates and protease inhibitors, Arch Oral Biol 32:599–605, 1987. Cox SW, Eley BM: Identification of a tryptase-like enzyme in extracts of inflamed human gingiva by effector and gel filtration studies, Arch Oral Biol 34:219–221, 1989a. Cox SW, Eley BM: Tryptase-like activity in crevicular fluid from gingivitis and periodontitis patients, J Periodontal Res 24:41–44, 1989b. Cox SW, Eley BM: The detection of cathepsin B and L-, elastase-, tryptase-, trypsin-, and dipeptidyl peptidase IV-like activities in crevicular fluid from gingivitis and periodontitis patients with peptidyl derivatives of 7-amino-4-trifluoromethyl coumarin, J Periodontal Res 24:353–361, 1989c. Cox SW, Eley BM: Cathepsin B/L-, elastase-, tryptase-, trypsin- and dipeptidylpeptidase IV-like activities in gingival crevicular fluid: a comparison of levels before and after basic periodontal treatment, J Clin Periodontol 19:333–339, 1992. Cox SW, Gazi MI, Clark DT, et al: Host tissue and Porphyromonas gingivalis dipeptidyl peptidase activities in gingival crevicular fluid, J Dent Res 72:705, 1993. Cox SW, Eley BM, Proctor GB, et al: Elastase inhibitors from gingival homogenates, gingival epithelial cells and saliva, J Dent Res 80, , 2001, 1153Abstract 94. Cox SW, Eley BM, Carpenter GH, et al: Skin antileukoproteinase in gingival tissue homogenates and epithelial cell media, J Dent Res 82, , 2003, C-51 281 Abstract. Cox SW, Eley BM, Kiili M, et al: Collagen degradation by interleukin-Ib-stimulated gingival fibroblasts is accompanied by release and activation of multiple matrix metalloproteinases and cysteine proteinases, Oral Dis 12:34–40, 2006a. Cox SW, Rodriguez-Gonzalez EM, Booth V, et al: Secretory leukocyte protease inhibitor and its potential interactions with elastase and cathepsin B in gingival crevicular fluid and saliva from patients with chronic periodontitis, J Periodontal Res 41:477–485, 2006b. Crystal RG: Impact of cell and molecular biology on pulmonary disease. In Isslebacher KJ, Braunwald E, Wilson JD, editors: Harrison’s Principles of Internal Medicine, New York, 1994, McGraw Hill, pp 1147–1151. Curtis MA, Ramakrishnan M, Slaney JM: Characterization of the trypsin-like enzymes of P. Gingivalis W83 using a radio-labelled active-site-directed inhibitor, J Gen Microbiol 139:949–955, 1993. Curtis MA, Aduse-Opoku J, Slaney JM, et al: Characterization of an adherence and antigenic determinant of the R1 protease of Porphyromonas gingivalis which is present on multiple gene products, Infect Immun 64:2532–2539, 1996. Curtis MA, Kuramitsu HK, Lantz M, et al: Molecular genetics and nomenclature of proteases of Porphyromonas gingivalis, J Periodontal Res 34:464–472, 1999. Curtis MA, Slaney JM, Aduse-Opoku J: Critical pathways in microbial virulence, J Clin Periodontol 32:28–38, 2005. D’Aiuto F, Parkar M, Andreou G, et al: Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers, J Dent Res 83:156–160, 2004. Dahl M, Nordestgaard BG, Lange P, et al: Molecular diagnosis of intermediate and severe a1-Antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals, Clin Chem 47:56–62, 2001. Darveau RP, Belton CM, Reife RA, et al: Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis, Infect Immun 66:1660–1665, 1998. Dayan S, Stashenko P, Niederman R, et al: Oral epithelial over expression of IL-1a causes periodontal disease, J Dent Res 83:786–790, 2004. De CarloJr AA, Windsor LJ, Bodden NK, et al: Activation and novel processing of matrix metalloproteinases by a thiol-proteinase from the oral anaerobe Porphyromonas gingivalis, J Dent Res 76:1260–1270, 1997. Delaissé JM, Engsig MT, Everts V, et al: Proteinases in bone resorption: obvious and less obvious roles, Clinica Chimica Acta 291:223–234, 2000. De-Waal-Malefyt R, Haanen J, Splits H, et al: Interleukin-10 and viral IL-10 strongly reduced antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via complex expression, J Exp Med 174:915–924, 1991. Dewhirst FE: N-acetyl muramyl dipeptide stimulation of bone resorption in tissue culture, Infect Immun 35:133–137, 1982. Dewhirst FE, Stashenko PP, Mole JE, et al: Purification and partial sequence of osteoclast-activation factor: identity with interleukin-1-beta, J Immunol 135:2562– 2568, 1985. Dickinson DP: Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease, Crit Rev Oral Biol Med 13:238–275, 2002. Dierickx K, Pauwels M, Laine ML, et al: Adhesion of Porphyromonas gingivalis serotypes to pocket epithelium, J Periodontol 74:844–848, 2003. Dietrich FE, Goodson JM, Raisz LG: Stimulation of bone resorption by various prostaglandins in organ culture, Prostaglandins 10:231–240, 1975. Dodds RA, Connor JR, Drake F, et al: Cathepsin K mrna detection is restricted to osteoclasts during fetal mouse development, J Bone Miner Res 13:673–682, 1998.
Page 2 and 3:
Periodoncia Sexta edición
Page 4 and 5:
Sexta edición Periodoncia B.M. Ele
Page 6 and 7:
Índice de capítulos Prefacio a la
Page 8 and 9:
Prefacio a la sexta edición El con
Page 10 and 11:
Tejidos periodontales 1 El sistema
Page 12 and 13:
Tejidos periodontales 3 © ELSEV
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Tejidos periodontales 11 entorno
Page 22 and 23:
Tejidos periodontales 13 © ELSE
Page 24 and 25:
Tejidos periodontales 15 Segundo
Page 26 and 27:
Tejidos periodontales 17 © ELSE
Page 28 and 29:
Entorno bucal sano y enfermo 2 La m
Page 30 and 31:
Entorno bucal sano y enfermo 21
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Interacción huésped-parásito 3 L
Page 38 and 39:
Interacción huésped-parásito
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Etiología de la enfermedad periodo
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57: Etiología de la enfermedad periodo
Page 66 and 67: Mecanismos de producción de la enf
Page 68 and 69: Mecanismos de producción de la
Page 116 and 117: Efecto de los factores sistémicos
Page 118 and 119: Efecto de los factores sistémic
Page 136 and 137: Síndrome de la inmunodeficiencia a
Page 138 and 139: Síndrome de la inmunodeficiencia a
Page 140 and 141: Historia natural de la enfermedad p
Page 142 and 143: Historia natural de la enfermeda
Page 148 and 149: Clasificación de las enfermedades
Page 150 and 151: Clasificación de las enfermedad
Page 152 and 153: Epidemiología de la enfermedad per
Page 154 and 155: Epidemiología de la enfermedad per
Page 156 and 157:
Epidemiología de la enfermedad per
Page 158 and 159:
Page 160 and 161:
Page 162 and 163:
Prevención de la enfermedad period
Page 164 and 165:
Page 166 and 167:
Page 168 and 169:
Page 170 and 171:
Page 172 and 173:
Manifestaciones clínicas de la enf
Page 174 and 175:
Manifestaciones clínicas de la
Page 176 and 177:
Diagnóstico, pronóstico y plan de
Page 178 and 179:
Diagnóstico, pronóstico y plan
Page 180 and 181:
Page 182 and 183:
Page 184 and 185:
Page 186 and 187:
Page 188 and 189:
Pruebas diagnósticas de actividad
Page 190 and 191:
Page 192 and 193:
Page 194 and 195:
Page 196 and 197:
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Tratamiento básico de la gingiv
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Uso de antisépticos, enzimas y
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Posible uso de antibióticos com
Page 254 and 255:
Page 256 and 257:
Page 258 and 259:
Page 260 and 261:
Page 262 and 263:
Page 264 and 265:
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Page 274 and 275:
Page 276 and 277:
Page 278 and 279:
Page 280 and 281:
Profilaxis antibiótica en paciente
Page 282 and 283:
Profilaxis antibiótica en pacie
Page 284 and 285:
Page 286 and 287:
Page 288 and 289:
Page 290 and 291:
Page 292 and 293:
Tratamiento periodontal quirúrgico
Page 294 and 295:
Tratamiento periodontal quirúrg
Page 296 and 297:
Page 298 and 299:
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Tratamiento de los defectos óseos
Page 306 and 307:
Tratamiento de los defectos óse
Page 308 and 309:
Page 310 and 311:
Page 312 and 313:
Page 314 and 315:
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Problemas mucogingivales y su tr
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Page 344 and 345:
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Abscesos periodontales 22 Absceso P
Page 360 and 361:
Abscesos periodontales 351 gramp
Page 362 and 363:
Periodontitis de inicio precoz (per
Page 364 and 365:
Periodontitis de inicio precoz (
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Page 372 and 373:
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Lesiones agudas e infecciosas de
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
Gingivitis ulceronecrosante 25 Los
Page 388 and 389:
Gingivitis ulceronecrosante 379
Page 390 and 391:
Épulis y tumores de las encías y
Page 392 and 393:
Épulis y tumores de las encías
Page 394 and 395:
Oclusión 385 © ELSEVIER. Fotoc
Page 396 and 397:
Oclusión 387 con afección peri
Page 398 and 399:
Oclusión 389 Bibliografía Harr
Page 400 and 401:
Ferulización 391 © ELSEVIER. F
Page 402 and 403:
Implantes dentales y periimplantolo
Page 404 and 405:
Implantes dentales y periimplant
Page 406 and 407:
Page 408 and 409:
Page 410 and 411:
Relación entre los tratamientos
Page 412 and 413:
Page 414 and 415:
Page 416 and 417:
Page 418 and 419:
Índice alfabético 409 © ELSEVIER
Page 420 and 421:
Page 422 and 423:
Page 424 and 425:
Page 426 and 427:
Page 428 and 429:
Page 430 and 431:
Page 432 and 433:
Esta página se dejó intencionalme
show all

Periodoncia.Eley.6a.Ed

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?